Fri.Mar 29, 2024

article thumbnail

Professional Beauty Association Announces Immersive Salon Leaders Experience

Beauty Launchpad

Aimed at fostering leadership and growth for salon owners and management, this groundbreaking event promises a unique and immersive experience, featuring expert-led sessions and peer-to-peer learning opportunities.

Salon 98
article thumbnail

Clariant’s CycloRetin Taps Cyclic Peptides for a Retinol and Bakuchiol Alternative

MedEsthetics

CycloRetin's heterophyllin B molecule is a cyclic peptide that enhances skin matrix production, per Clariant, thereby improving collagen and reducing the signs of aging.

Retinol 78
article thumbnail

You’ve Been Warned: FDA Red Flags Select OTC Topical Analgesics

The Dermatology Digest

By Ted Rosen, MD The U.S. Food and Drug Administration has issued a warning regarding select over-the-counter topical analgesics, typically used before, during, or after certain cosmetic procedures such as microdermabrasion, laser hair removal, tattooing, tattoo removal, and skin piercing. It is possible that some of us recommend/sell/dispense/use the products listed in this warning (see below).

article thumbnail

The Weekly Roundup: March 25-29

Dermatology Times

ICYMI, this week we had news about bringing awareness to ethics in aesthetics, the 7 year anniversary of dupilumab's approval for atopic dermatitis, and more.

Ethics 74
article thumbnail

Is Avobenzone In Sunscreen Dangerous?

Beautiful With Brains - Ingredients

Can you guess what’s the most used UV filter in the whole world? *drumroll* Avobenzone! The reason is simple: it’s the only UVA filter available all over the world that doesn’t turn your face into a white, greasy mess. Yes, other UVA filters exist, but they’re either not been approved for use in big countries […] The post Is Avobenzone In Sunscreen Dangerous?

article thumbnail

EltaMD Rings Bell at New York Stock Exchange as Continued Celebration of National Dermatologist Day

Dermatology Times

EltaMD representatives and dermatologists partook in the celebration on March 28 as a continuation of the celebration and momentum of the newly-established National Dermatologist Day.

69

More Trending

article thumbnail

Discovering Dermatology Times: March 2024 Print

Dermatology Times

Learn more about the in-depth topics covered in the March 2024 print issue of Dermatology Times.

article thumbnail

Skin Biomarkers May Predict Early Risk of Food Allergies or AD in Infants; Prevention Trial Underway

The Dermatology Digest

Skin biomarkers in infants may help predict early development of food allergies and atopic dermatitis (AD), according to research out of National Jewish Health in Denver. The study, which appears in the March 2024 issue of the Journal of Allergy & Clinical Immunology , found that abnormal lipids, microbes and proteins on infant’s skin can predict the development of food allergies or AD, and now researchers are working to develop an anti-inflammatory cream that can stop these conditio

article thumbnail

Hidradenitis Suppurativa in Transgender and Gender-Diverse Patients and Hormone Therapy

Dermatology Times

Researchers found that patients who initiated gender-affirming hormone therapy with testosterone were more likely to experience a worsening of their HS symptoms.

Therapy 60
article thumbnail

My Salon Suite Expands Portfolio with Acquisition of Mera Salon Suites

Skin Inc

The acquisition comes amid My Salon Suite's ongoing strategy for growth, which resulted in more than 40 franchise agreements and 43 store openings for the brand in 2023.

article thumbnail

Prevalence and QoL of Hand and Foot AD

Dermatology Times

Alexandra Golant, MD, delves into the prevalence and profound influence of hand and foot involvement in her patients, shedding light on the significant burden it imposes on their quality of life.

45
article thumbnail

U.S. Dermatology Partners Welcomes Juan Estrada, MD to Kyle, Texas

US Dermatologt Partners

Kyle, Texas – U.S. Dermatology Partners is pleased to welcome Board-Certified Dermatologist Dr. Juan Estrada to their Kyle, Texas office. Board-Certified Dermatologist Dr. Juan Estrada Joins U.S. Dermatology Partners at Their Office in Kyle, Texas Dr. Estrada earned his medical degree from Columbia University College of Physicians and Surgeons in New York.

article thumbnail

Barrier Function and Atopic Dermatitis

Dermatology Times

A dermatology expert reviews the role of barrier function in AD and outlines available treatments, emphasizing the importance of moisturizing and rapid options when appropriate, as well as the efficacy of rapid systemic treatments in patients when appropriate.

article thumbnail

Next Generation Melanoma Vaccine May Boost Long-term Survival, Especially in Young Men

The Dermatology Digest

A second-generation melanoma vaccine improves long-term survival for melanoma patients, especially among younger men, new research shows. The vaccine developers enhanced the effectiveness of their first-generation melanoma vaccine by simultaneously stimulating helper T cells to recognize melanoma proteins, in addition to weaponizing killer T cells against melanoma.

Therapy 57
article thumbnail

Dermatology Times March 2024 Recap

Dermatology Times

Dermatology Times is looking back on the top stories in dermatology from the month of March.

article thumbnail

Interview Intersection: Expert Interviews From March 2024

Dermatology Times

Dermatology Times is recapping our top expert interviews from the month of March.

article thumbnail

Rethinking Itch Severity in Atopic Dermatitis

Dermatology Times

Brian Kim, MD, underscores the critical gap in addressing severe itch in atopic dermatitis, often overshadowed by the visible manifestations of skin rash.

article thumbnail

Exploring Long-Term Data and Combination Therapies

Dermatology Times

Brian Kim, MD, explores long-term ruxolitinib data and combination therapies in the treatment of pediatric atopic dermatitis.

Therapy 36
article thumbnail

Personalizing Treatment Approaches For Each Unique Patient

Dermatology Times

Christopher Bunick, MD, PhD, expands on how clinicians can personalize treatment plans for each patient.

article thumbnail

Benchmarks for Optimal Outcomes in AD Treatment

Dermatology Times

Christopher Bunick, MD, PhD, reviews benchmarks for optimal outcomes in patients with atopic dermatitis and compares treatments available.